speb/financial-data huggingface dataset:
Insider transaction \u2014 GSF.L, 2025-03-31
Insider: Redmayne Bentley LLP
Shares: 0
Insider transaction \u2014 GSF.L, 2025-03-31
Insider: Scenna (Lisa)
Shares: 0
Insider transaction \u2014 GSF.L, 2025-04-03
Insider: RM Capital Markets Ltd
Shares: 5228676
Insider transaction \u2014 GSF.L, 2025-04-14
Insider: King (Malcolm Robert)
Shares: 30000
Value: 22950.00
Bought at price 0.76 per share.
Insider transaction \u2014 GSF.L, 2025-06-06
Insider: RM Capital Markets Ltd
Shares: 4928078
Insider transaction \u2014 GSF.L, 2025-06-20
Insider: Stichting Juridisch Eigendom Privium Sustainable Impact Fund
Shares: 4597824
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: 1st Avenue Capital LLC
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Banszky (Caroline Janet)
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Charles Stanley Group PLC
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Cox (Patrick)
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Credo Global Equity Fund IC Ltd.
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: EFG Private Bank, Ltd
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: King (Malcolm Robert)
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Murley (Thomas S)
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: RM Capital Markets Ltd
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Rathbone Investment Management Ltd
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Redmayne Bentley LLP
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Scenna (Lisa)
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-16
Insider: Stichting Juridisch Eigendom Privium Sustainable Impact Fund
Shares: 0
Insider transaction \u2014 GSF.L, 2025-07-21
Insider: RM Capital Markets Ltd
Shares: 4983879
Insider transaction \u2014 GSF.L, 2025-08-08
Insider: Rathbone Investment Management Ltd
Shares: 25586211
Insider transaction \u2014 GSF.L, 2025-12-15
Insider: BMO Asset Management, Inc.
Shares: 0
Insider transaction \u2014 GSF.L, 2025-12-17
Insider: Jefferies Asset Management, LLC
Shares: 0
Insider transaction \u2014 GSF.L, 2025-12-17
Insider: Lennox (Angus Gordon)
Shares: 200000
Value: 147200.00
Bought at price 0.74 per share.
Insider transaction \u2014 GSF.L, 2025-12-17
Insider: Merriweather (Simon)
Shares: 7000
Value: 5054.00
Bought at price 0.72 per share.
Insider transaction \u2014 GSF.L, 2025-12-18
Insider: Merriweather (Simon)
Shares: 13000
Value: 9568.00
Bought at price 0.74 per share.
Insider transaction \u2014 GSF.L, 2026-01-13
Insider: Saba Capital Management
Shares: 0
Insider transaction \u2014 GSF.L, 2026-01-15
Insider: Jefferies Asset Management, LLC
Shares: 441641
Insider transaction \u2014 GSF.L, 2026-01-26
Insider: BMO Asset Management, Inc.
Shares: 0
Insider transaction \u2014 GSF.L, 2026-01-26
Insider: Jefferies Asset Management, LLC
Shares: 839508
Insider transaction \u2014 GSF.L, 2026-01-27
Insider: Jefferies Asset Management, LLC
Shares: 1851773
Insider transaction \u2014 GSF.L, 2026-02-03
Insider: BMO Asset Management, Inc.
Shares: 0
Insider transaction \u2014 GSF.L, 2026-02-19
Insider: Jefferies Asset Management, LLC
Shares: 1435711
Insider transaction \u2014 GSF.L, 2026-02-24
Insider: RM Capital Markets Ltd
Shares: 5950000
Insider transaction \u2014 GSF.L, 2026-02-24
Insider: Saba Capital Management
Shares: 21782
Insider transaction \u2014 GSF.L, 2026-02-25
Insider: Jefferies Asset Management, LLC
Shares: 7218277
Insider transaction \u2014 GSF.L, 2026-02-27
Insider: BMO Asset Management, Inc.
Shares: 0
Insider transaction \u2014 GSF.L, 2026-02-27
Insider: Jefferies Asset Management, LLC
Shares: 0
Insider transaction \u2014 GSF.L, 2026-03-04
Insider: Jefferies Asset Management, LLC
Shares: 3998408
Insider transaction \u2014 GSF.L, 2026-03-19
Insider: Saba Capital Management
Shares: 600
Insider transaction \u2014 GSF.L, 2026-03-23
Insider: Crighton (Norman)
Shares: 50000
Value: 36250.00
Bought at price 0.72 per share.
Insider transaction \u2014 GSF.L, 2026-05-07
Insider: Jefferies Asset Management, LLC
Shares: 161579
Insider transaction \u2014 GSF.L, 2026-05-11
Insider: Jefferies Asset Management, LLC
Shares: 32416
Insider transaction \u2014 GSF.L, 2026-05-22
Insider: Jefferies Asset Management, LLC
Shares: 4103291
Insider transaction \u2014 GSF.L, 2026-06-17
Insider: Saba Capital Management
Shares: 2250230
Insider transaction \u2014 GSF.L, 2026-06-19
Insider: Jefferies Asset Management, LLC
Shares: 3233598
Insider transaction \u2014 GSF.L, 2026-06-22
Insider: Jefferies Asset Management, LLC
Shares: 39036
Insider transaction \u2014 GSF.L, 2026-07-15
Insider: Saba Capital Management
Shares: 1434762
Insider transaction \u2014 GSF.L, 2026-07-16
Insider: Jefferies Asset Management, LLC
Shares: 7269312
Insider transaction \u2014 GSF.L, 2026-07-21
Insider: Jefferies Asset Management, LLC
Shares: 25532398
Insider transaction \u2014 GSHD, 2024-08-13
Insider: JONES ROBYN MARY ELIZABETH
Position: Director and Beneficial Owner of more than 10% of a Class of Security
Shares: 2000
Value: 0.00
Stock Gift at price 0.00 per share.
Insider transaction \u2014 GSHD, 2024-08-15
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 10000
Value: 851691.00
Sale at price 85.10 - 85.19 per share.
Insider transaction \u2014 GSHD, 2024-08-15
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 10000
Value: 408800.00
Conversion of Exercise of derivative security at price 40.88 per share.
Insider transaction \u2014 GSHD, 2024-08-19
Insider: JONES ROBYN MARY ELIZABETH
Position: Director and Beneficial Owner of more than 10% of a Class of Security
Shares: 6000
Value: 0.00
Stock Gift at price 0.00 per share.
Insider transaction \u2014 GSHD, 2024-08-23
Insider: JONES ROBYN MARY ELIZABETH
Position: Director and Beneficial Owner of more than 10% of a Class of Security
Shares: 625
Value: 0.00
Stock Gift at price 0.00 per share.
Insider transaction \u2014 GSHD, 2024-09-25
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 4814
Value: 434512.00
Sale at price 90.26 per share.
Insider transaction \u2014 GSHD, 2024-09-25
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 4814
Value: 196796.00
Conversion of Exercise of derivative security at price 40.88 per share.
Insider transaction \u2014 GSHD, 2024-09-30
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 5186
Value: 212004.00
Conversion of Exercise of derivative security at price 40.88 per share.
Insider transaction \u2014 GSHD, 2024-09-30
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 5186
Value: 467961.00
Sale at price 90.09 - 90.34 per share.
Insider transaction \u2014 GSHD, 2024-10-15
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 10000
Value: 408800.00
Conversion of Exercise of derivative security at price 40.88 per share.
Insider transaction \u2014 GSHD, 2024-10-15
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 10000
Value: 953500.00
Sale at price 95.35 per share.
Insider transaction \u2014 GSHD, 2024-10-16
Insider: JONES ADRIENNE KEBODEAUX
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 6072
Value: 607504.00
Sale at price 100.05 per share.
Insider transaction \u2014 GSHD, 2024-10-16
Insider: JONES ADRIENNE KEBODEAUX
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 6072
Insider transaction \u2014 GSHD, 2024-10-24
Insider: JONES ADRIENNE KEBODEAUX
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 43928
Insider transaction \u2014 GSHD, 2024-10-24
Insider: JONES ADRIENNE KEBODEAUX
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 43928
Value: 4401986.00
Sale at price 100.14 - 101.08 per share.
Insider transaction \u2014 GSHD, 2024-11-01
Insider: JONES ROBYN MARY ELIZABETH
Position: Director and Beneficial Owner of more than 10% of a Class of Security
Shares: 9100
Value: 0.00
Stock Gift at price 0.00 per share.
Insider transaction \u2014 GSHD, 2024-11-07
Insider: MILLER MARK
Position: Chief Executive Officer
Shares: 61622
Value: 616220.00
Conversion of Exercise of derivative security at price 10.00 per share.
Insider transaction \u2014 GSHD, 2024-11-07
Insider: MILLER MARK
Position: Chief Executive Officer
Shares: 61622
Value: 6791049.00
Sale at price 110.00 - 111.16 per share.
Insider transaction \u2014 GSHD, 2025-02-28
Insider: CRUZADO WADED
Position: Director
Shares: 8450
Value: 490100.00
Conversion of Exercise of derivative security at price 58.00 per share.
Insider transaction \u2014 GSHD, 2025-02-28
Insider: CRUZADO WADED
Position: Director
Shares: 8450
Value: 1002151.00
Sale at price 118.44 - 119.77 per share.
Insider transaction \u2014 GSHD, 2025-02-28
Insider: JONES MARK EVAN JR.
Position: Chief Financial Officer
Shares: 1010
Value: 119200.00
Purchase at price 118.02 per share.
Insider transaction \u2014 GSHD, 2025-02-28
Insider: MCCONNON THOMAS E.
Position: Director
Shares: 205000
Value: 24875730.00
Sale at price 121.05 - 123.21 per share.
Insider transaction \u2014 GSHD, 2025-03-06
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 28361
Insider transaction \u2014 GSHD, 2025-03-06
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 28361
Value: 3476996.00
Sale at price 120.55 - 124.35 per share.
Insider transaction \u2014 GSHD, 2025-03-12
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 500
Value: 60060.00
Sale at price 120.12 per share.
Insider transaction \u2014 GSHD, 2025-03-12
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 500
Insider transaction \u2014 GSHD, 2025-03-25
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 71139
Insider transaction \u2014 GSHD, 2025-03-25
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 71139
Value: 8581784.00
Sale at price 120.29 - 121.21 per share.
Insider transaction \u2014 GSHD, 2025-05-09
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 67302
Value: 6884108.00
Sale at price 101.73 - 103.20 per share.
Insider transaction \u2014 GSHD, 2025-05-09
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 67302
Insider transaction \u2014 GSHD, 2025-05-13
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 161313
Value: 16921168.00
Sale at price 102.20 - 105.51 per share.
Insider transaction \u2014 GSHD, 2025-05-13
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 161313
Insider transaction \u2014 GSHD, 2025-05-14
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 21385
Insider transaction \u2014 GSHD, 2025-05-14
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 21385
Value: 2240381.00
Sale at price 104.76 - 105.20 per share.
Insider transaction \u2014 GSHD, 2025-05-14
Insider: O'CONNOR JOHN TERRY
Position: General Counsel
Shares: 2500
Value: 88125.00
Conversion of Exercise of derivative security at price 35.25 per share.
Insider transaction \u2014 GSHD, 2025-05-14
Insider: O'CONNOR JOHN TERRY
Position: General Counsel
Shares: 2500
Value: 261050.00
Sale at price 104.42 per share.
Insider transaction \u2014 GSHD, 2025-05-15
Insider: JONES ROBYN MARY ELIZABETH
Position: Director and Beneficial Owner of more than 10% of a Class of Security
Shares: 92000
Value: 0.00
Stock Gift at price 0.00 per share.
Insider transaction \u2014 GSHD, 2025-05-20
Insider: LANGSTON LINDY
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 1105
Insider transaction \u2014 GSHD, 2025-05-20
Insider: LANGSTON LINDY
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 1105
Value: 121605.00
Sale at price 110.05 per share.
Insider transaction \u2014 GSHD, 2025-05-28
Insider: LANGSTON LINDY
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 13895
Value: 1531115.00
Sale at price 110.16 - 110.20 per share.
Insider transaction \u2014 GSHD, 2025-05-28
Insider: LANGSTON LINDY
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 13895
Insider transaction \u2014 GSHD, 2025-07-29
Insider: JONES MARK EVAN JR.
Position: Chief Financial Officer
Shares: 1149
Value: 98906.00
Purchase at price 86.08 per share.
Insider transaction \u2014 GSHD, 2025-07-31
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 31516
Value: 2938552.00
Sale at price 93.24 per share.
Insider transaction \u2014 GSHD, 2025-07-31
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 31516
Insider transaction \u2014 GSHD, 2025-08-07
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 19228
Insider transaction \u2014 GSHD, 2025-08-07
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 19228
Value: 1683161.00
Sale at price 87.14 - 89.41 per share.
Insider transaction \u2014 GSHD, 2025-08-11
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 60715
Value: 5259279.00
Sale at price 86.41 - 88.15 per share.
Insider transaction \u2014 GSHD, 2025-08-11
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 60715
Insider transaction \u2014 GSHD, 2025-08-13
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 108320
Value: 9502809.00
Sale at price 86.44 - 90.09 per share.
Insider transaction \u2014 GSHD, 2025-08-13
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 108320
Insider transaction \u2014 GSHD, 2025-08-15
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 21991
Value: 1926035.00
Sale at price 87.01 - 89.29 per share.
Insider transaction \u2014 GSHD, 2025-08-15
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 21991
Insider transaction \u2014 GSHD, 2025-08-19
Insider: JONES ADRIENNE KEBODEAUX
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 3000
Value: 258900.00
Sale at price 86.30 per share.
Insider transaction \u2014 GSHD, 2025-08-19
Insider: JONES ADRIENNE KEBODEAUX
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 3000
Insider transaction \u2014 GSHD, 2025-10-27
Insider: JONES MARK EVAN JR.
Position: Chief Operating Officer
Shares: 873
Value: 64986.00
Purchase at price 74.44 - 74.45 per share.
Insider transaction \u2014 GSHD, 2025-11-26
Insider: O'CONNOR JOHN TERRY
Position: General Counsel
Shares: 2100
Value: 150801.00
Purchase at price 71.81 per share.
Insider transaction \u2014 GSHD, 2025-11-28
Insider: MILLER MARK
Position: Chief Executive Officer
Shares: 5000
Value: 361700.00
Purchase at price 72.34 per share.
Insider transaction \u2014 GSHD, 2025-12-01
Insider: MCCONNON THOMAS E.
Position: Director
Shares: 69686
Value: 5130522.00
Sale at price 73.60 - 74.56 per share.
Insider transaction \u2014 GSHD, 2026-02-20
Insider: GOLDBERG LOUIS
Position: Director
Shares: 5575
Value: 250039.00
Purchase at price 44.85 per share.
Insider transaction \u2014 GSHD, 2026-04-29
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 5486
Value: 263889.00
Sale at price 48.07 - 49.06 per share.
Insider transaction \u2014 GSHD, 2026-04-29
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 5486
Insider transaction \u2014 GSHD, 2026-05-01
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 5090
Value: 230679.00
Sale at price 45.32 per share.
Insider transaction \u2014 GSHD, 2026-05-01
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 5090
Insider transaction \u2014 GSHD, 2026-05-14
Insider: MILLER MARK
Position: Chief Executive Officer
Shares: 5000
Value: 184450.00
Purchase at price 36.89 per share.
Insider transaction \u2014 GSHD, 2026-05-15
Insider: JONES MARK EVAN JR.
Position: President
Shares: 2650
Value: 99375.00
Purchase at price 37.50 per share.
Insider transaction \u2014 GSHD, 2026-05-18
Insider: THORNTHWAITE MARTIN ELLIS
Position: General Counsel
Shares: 5000
Value: 207500.00
Purchase at price 41.50 per share.
Insider transaction \u2014 GSHD, 2026-05-21
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 70751
Value: 2926610.00
Sale at price 40.62 - 42.21 per share.
Insider transaction \u2014 GSHD, 2026-05-21
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 70751
Insider transaction \u2014 GSHD, 2026-05-22
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 82689
Insider transaction \u2014 GSHD, 2026-05-22
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 82689
Value: 3453750.00
Sale at price 41.74 - 42.43 per share.
Insider transaction \u2014 GSHD, 2026-05-27
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 9588
Insider transaction \u2014 GSHD, 2026-05-27
Insider: MARK & ROBYN JONES DESCENDANTS TRUST 2014
Position: Trustee
Shares: 9588
Value: 390814.00
Sale at price 40.51 - 41.28 per share.
Insider transaction \u2014 GSHD, 2026-05-28
Insider: MARTIN JOHN ARTHUR
Position: Chief Financial Officer
Shares: 5000
Value: 173650.00
Purchase at price 34.73 per share.
Insider transaction \u2014 GSHD, 2026-05-29
Insider: LANGSTON PATRICK RYAN
Position: Beneficial Owner of more than 10% of a Class of Security
Shares: 2800
Value: 99568.00
Purchase at price 35.56 per share.
Insider transaction \u2014 GSI.V, 2025-07-04
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 5000
Value: 5145.00
Disposition in the public market at price 1.03 per share.
Insider transaction \u2014 GSI.V, 2025-07-08
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 10000
Value: 10540.00
Disposition in the public market at price 1.05 per share.
Insider transaction \u2014 GSI.V, 2025-09-03
Insider: Dyment (Douglas)
Position: 10% Security Holder of Issuer
Shares: 1368209
Value: 1587122.00
Disposition in the public market at price 1.16 per share.
Insider transaction \u2014 GSI.V, 2025-09-03
Insider: Dyment (Douglas)
Position: 10% Security Holder of Issuer
Shares: 2631791
Value: 3052877.00
Disposition in the public market at price 1.16 per share.
Insider transaction \u2014 GSI.V, 2025-10-10
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 34770
Value: 75485.00
Disposition in the public market at price 2.17 per share.
Insider transaction \u2014 GSI.V, 2025-10-10
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 20000
Value: 43280.00
Disposition in the public market at price 2.16 per share.
Insider transaction \u2014 GSI.V, 2025-10-10
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 18000
Value: 38682.00
Disposition in the public market at price 2.15 per share.
Insider transaction \u2014 GSI.V, 2025-10-10
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 2000
Value: 4298.00
Disposition in the public market at price 2.15 per share.
Insider transaction \u2014 GSI.V, 2025-10-10
Insider: Fraser (Douglas S)
Position: Senior Officer of Issuer
Shares: 30000
Value: 64710.00
Disposition in the public market at price 2.16 per share.
Insider transaction \u2014 GSI.V, 2026-03-27
Insider: Dyment (Douglas)
Position: 10% Security Holder of Issuer
Shares: 500000
Value: 47000.00
Exercise of options at price 0.09 per share.
Insider transaction \u2014 GSI.V, 2026-07-17
Insider: Chin (Kelsey)
Position: Director of Issuer
Shares: 150000
Value: 20550.00
Exercise of options at price 0.14 per share.
Insider transaction \u2014 GSIT, 2024-07-31
Insider: NELSON BARBARA H
Position: Director
Shares: 9890
Value: 18494.00
Conversion of Exercise of derivative security at price 1.87 per share.
Insider transaction \u2014 GSIT, 2024-07-31
Insider: NELSON BARBARA H
Position: Director
Shares: 9890
Value: 27808.00
Sale at price 2.81 - 2.82 per share.
Insider transaction \u2014 GSIT, 2024-08-01
Insider: NELSON BARBARA H
Position: Director
Shares: 100
Value: 187.00
Conversion of Exercise of derivative security at price 1.87 per share.
Insider transaction \u2014 GSIT, 2024-08-01
Insider: NELSON BARBARA H
Position: Director
Shares: 100
Value: 280.00
Sale at price 2.80 per share.
Insider transaction \u2014 GSIT, 2024-08-15
Insider: NELSON BARBARA H
Position: Director
Shares: 17015
Value: 31818.00
Conversion of Exercise of derivative security at price 1.87 per share.
Insider transaction \u2014 GSIT, 2024-08-15
Insider: NELSON BARBARA H
Position: Director
Shares: 17015
Value: 38313.00
Sale at price 2.22 - 2.30 per share.
Insider transaction \u2014 GSIT, 2025-08-05
Insider: AKERIB AVIDAN
Position: Officer
Shares: 10000
Value: 34000.00
Conversion of Exercise of derivative security at price 3.40 per share.
Insider transaction \u2014 GSIT, 2025-08-05
Insider: AKERIB AVIDAN
Position: Officer
Shares: 10000
Value: 38947.00
Sale at price 3.89 per share.
Insider transaction \u2014 GSIT, 2025-08-07
Insider: BRADLEY JACK A
Position: Director
Shares: 8000
Value: 26620.00
Sale at price 3.30 - 3.50 per share.
Insider transaction \u2014 GSIT, 2025-10-31
Insider: LU RUEY LIN
Position: Director
Shares: 4000
Value: 17360.00
Conversion of Exercise of derivative security at price 4.34 per share.
Insider transaction \u2014 GSIT, 2025-11-04
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 361600.00
Sale at price 9.04 per share.
Insider transaction \u2014 GSIT, 2025-11-04
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 199600.00
Conversion of Exercise of derivative security at price 4.99 per share.
Insider transaction \u2014 GSIT, 2025-11-05
Insider: AKERIB AVIDAN
Position: Officer
Shares: 190018
Value: 1691334.00
Sale at price 8.54 - 9.05 per share.
Insider transaction \u2014 GSIT, 2025-11-05
Insider: AKERIB AVIDAN
Position: Officer
Shares: 190018
Value: 646061.00
Conversion of Exercise of derivative security at price 3.40 per share.
Insider transaction \u2014 GSIT, 2025-11-06
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 346552.00
Sale at price 8.66 per share.
Insider transaction \u2014 GSIT, 2025-11-06
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 83800.00
Conversion of Exercise of derivative security at price 1.92 - 2.27 per share.
Insider transaction \u2014 GSIT, 2026-03-02
Insider: CHUANG PATRICK T
Position: Officer
Shares: 20000
Value: 167310.00
Sale at price 8.37 per share.
Insider transaction \u2014 GSIT, 2026-03-02
Insider: CHUANG PATRICK T
Position: Officer
Shares: 20000
Value: 73600.00
Conversion of Exercise of derivative security at price 3.68 per share.
Insider transaction \u2014 GSIT, 2026-03-10
Insider: WU BOR TAY
Position: Officer
Shares: 40000
Value: 199600.00
Conversion of Exercise of derivative security at price 4.99 per share.
Insider transaction \u2014 GSIT, 2026-03-10
Insider: WU BOR TAY
Position: Officer
Shares: 40000
Value: 346544.00
Sale at price 8.66 per share.
Insider transaction \u2014 GSIT, 2026-03-13
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 223200.00
Conversion of Exercise of derivative security at price 5.58 per share.
Insider transaction \u2014 GSIT, 2026-03-13
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 342440.00
Sale at price 8.56 per share.
Insider transaction \u2014 GSIT, 2026-03-17
Insider: SHU LEE LEAN
Position: Chief Executive Officer
Shares: 67251
Value: 335582.00
Conversion of Exercise of derivative security at price 4.99 per share.
Insider transaction \u2014 GSIT, 2026-03-17
Insider: SHU LEE LEAN
Position: Chief Executive Officer
Shares: 67251
Value: 673628.00
Sale at price 10.01 - 10.02 per share.
Insider transaction \u2014 GSIT, 2026-05-11
Insider: SHU LEE LEAN
Position: Chief Executive Officer
Shares: 143062
Value: 1640207.00
Sale at price 10.09 - 12.01 per share.
Insider transaction \u2014 GSIT, 2026-05-11
Insider: SHU LEE LEAN
Position: Chief Executive Officer
Shares: 143062
Value: 940879.00
Conversion of Exercise of derivative security at price 4.99 - 7.26 per share.
Insider transaction \u2014 GSIT, 2026-05-12
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 427088.00
Sale at price 10.68 per share.
Insider transaction \u2014 GSIT, 2026-05-12
Insider: CHUANG PATRICK T
Position: Officer
Shares: 40000
Value: 268000.00
Conversion of Exercise of derivative security at price 6.70 per share.
Insider transaction \u2014 GSIT, 2026-05-12
Insider: WU PING TAK
Position: Officer
Shares: 11763
Value: 127040.00
Sale at price 10.80 per share.
Insider transaction \u2014 GSIT, 2026-05-13
Insider: AKERIB AVIDAN
Position: Officer
Shares: 20000
Value: 123200.00
Conversion of Exercise of derivative security at price 6.16 per share.
Insider transaction \u2014 GSIT, 2026-05-13
Insider: AKERIB AVIDAN
Position: Officer
Shares: 20000
Value: 229500.00
Sale at price 11.47 - 12.03 per share.
Insider transaction \u2014 GSIT, 2026-05-13
Insider: SHU LEE LEAN
Position: Chief Executive Officer
Shares: 10313
Value: 128977.00
Sale at price 12.51 per share.
Insider transaction \u2014 GSIT, 2026-05-13
Insider: SHU LEE LEAN
Position: Chief Executive Officer
Shares: 10313
Value: 74872.00
Conversion of Exercise of derivative security at price 7.26 per share.
Insider transaction \u2014 GSIT, 2026-05-14
Insider: SCHIRLE DOUGLAS M
Position: Chief Financial Officer
Shares: 40000
Value: 452928.00
Sale at price 11.32 per share.
Insider transaction \u2014 GSIT, 2026-05-14
Insider: SCHIRLE DOUGLAS M
Position: Chief Financial Officer
Shares: 40000
Value: 199600.00
Conversion of Exercise of derivative security at price 4.99 per share.
Insider transaction \u2014 GSIT, 2026-05-21
Insider: LASSERRE DIDIER
Position: Officer
Shares: 30000
Value: 279180.00
Sale at price 9.31 per share.
Insider transaction \u2014 GSIT, 2026-05-21
Insider: LASSERRE DIDIER
Position: Officer
Shares: 30000
Value: 149700.00
Conversion of Exercise of derivative security at price 4.99 per share.
Insider transaction \u2014 GSIT, 2026-05-22
Insider: WU BOR TAY
Position: Officer
Shares: 40000
Value: 83800.00
Conversion of Exercise of derivative security at price 1.92 - 2.27 per share.
Insider transaction \u2014 GSIT, 2026-05-22
Insider: WU BOR TAY
Position: Officer
Shares: 40000
Value: 437358.00
Sale at price 10.93 per share.
Insider transaction \u2014 GSIT, 2026-05-26
Insider: WU PING TAK
Position: Officer
Shares: 30000
Value: 330396.00
Sale at price 11.01 per share.
Insider transaction \u2014 GSIT, 2026-05-26
Insider: WU PING TAK
Position: Officer
Shares: 30000
Value: 149700.00
Conversion of Exercise of derivative security at price 4.99 per share.
Insider transaction \u2014 GSIT, 2026-06-01
Insider: WU BOR TAY
Position: Officer
Shares: 20000
Value: 218658.00
Sale at price 10.93 per share.
Insider transaction \u2014 GSIT, 2026-06-01
Insider: WU BOR TAY
Position: Officer
Shares: 20000
Value: 73600.00
Conversion of Exercise of derivative security at price 3.68 per share.
Insider transaction \u2014 GSIT, 2026-06-02
Insider: CHUANG PATRICK T
Position: Officer
Shares: 80000
Value: 891648.00
Sale at price 10.98 - 11.31 per share.
Insider transaction \u2014 GSIT, 2026-06-02
Insider: CHUANG PATRICK T
Position: Officer
Shares: 80000
Value: 453600.00
Conversion of Exercise of derivative security at price 4.08 - 7.26 per share.
Insider transaction \u2014 GSIT, 2026-07-15
Insider: CHOLAWSKY ELIZABETH M.
Position: Director
Shares: 60517
Value: 115344.00
Conversion of Exercise of derivative security at price 1.87 - 3.69 per share.
Insider transaction \u2014 GSK, 2024-12-31
Insider: Anderson (Elizabeth McKee)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Bancroft (Charles A)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Barron (Hal V)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Beal (Anne M.D.)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Dietz (Hal)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Goodman (Jesse)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Lee (Jeannie)
Shares: 0
Insider transaction \u2014 GSK, 2024-12-31
Insider: Sikka (Vishal Ph.D.)
Shares: 0
Insider transaction \u2014 GSK, 2025-01-10
Insider: Anderson (Elizabeth McKee)
Shares: 21
Value: 700.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Bancroft (Charles A)
Shares: 139
Value: 4635.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Barron (Hal V)
Shares: 23
Value: 767.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Beal (Anne M.D.)
Shares: 18
Value: 600.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Dietz (Hal)
Shares: 18
Value: 600.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Goodman (Jesse)
Shares: 18
Value: 600.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Lee (Jeannie)
Shares: 6
Value: 200.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-10
Insider: Sikka (Vishal Ph.D.)
Shares: 80
Value: 2668.00
Bought at price 33.35 per share.
Insider transaction \u2014 GSK, 2025-01-14
Insider: Barron (Hal V)
Shares: 3422
Value: 109948.00
Bought at price 32.13 per share.
Insider transaction \u2014 GSK, 2025-01-14
Insider: Ramakrishnan (Shobie)
Shares: 184
Value: 5911.00
Bought at price 32.13 per share.
Insider transaction \u2014 GSK, 2025-02-17
Insider: Ramakrishnan (Shobie)
Shares: 11288
Value: 408286.00
Bought at price 36.17 per share.
Insider transaction \u2014 GSK, 2025-02-18
Insider: Barron (Hal V)
Shares: 24623
Value: 902186.00
Sold at price 36.64 per share.
Insider transaction \u2014 GSK, 2025-02-18
Insider: Ramakrishnan (Shobie)
Shares: 2786
Insider transaction \u2014 GSK, 2025-02-20
Insider: Anderson (Elizabeth McKee)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Bancroft (Charles A)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Barron (Hal V)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Beal (Anne M.D.)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Dietz (Hal)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Dodge & Cox
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Goodman (Jesse)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Lee (Jeannie)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-20
Insider: Sikka (Vishal Ph.D.)
Shares: 0
Insider transaction \u2014 GSK, 2025-02-21
Insider: Barron (Hal V)
Shares: 83
Value: 3041.00
Bought at price 36.64 per share.
Insider transaction \u2014 GSK, 2025-02-21
Insider: Barron (Hal V)
Shares: 3270
Value: 119812.00
Bought at price 36.64 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Anderson (Elizabeth McKee)
Shares: 248
Value: 9738.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Bancroft (Charles A)
Shares: 1969
Value: 77322.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Barron (Hal V)
Shares: 249
Value: 9778.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Beal (Anne M.D.)
Shares: 249
Value: 9778.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Dietz (Hal)
Shares: 249
Value: 9778.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Goodman (Jesse)
Shares: 249
Value: 9778.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Lee (Jeannie)
Shares: 249
Value: 9778.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-03-20
Insider: Sikka (Vishal Ph.D.)
Shares: 857
Value: 33654.00
Bought at price 39.27 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Anderson (Elizabeth McKee)
Shares: 26
Value: 887.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Bancroft (Charles A)
Shares: 174
Value: 5936.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Barron (Hal V)
Shares: 29
Value: 989.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Beal (Anne M.D.)
Shares: 22
Value: 750.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Dietz (Hal)
Shares: 22
Value: 750.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Goodman (Jesse)
Shares: 22
Value: 750.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Lee (Jeannie)
Shares: 10
Value: 341.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-04-11
Insider: Sikka (Vishal Ph.D.)
Shares: 98
Value: 3343.00
Bought at price 34.12 per share.
Insider transaction \u2014 GSK, 2025-05-16
Insider: Barron (Hal V)
Shares: 87
Value: 3274.00
Bought at price 37.64 per share.
Insider transaction \u2014 GSK, 2025-05-16
Insider: Barron (Hal V)
Shares: 3450
Value: 129858.00
Bought at price 37.64 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Anderson (Elizabeth McKee)
Shares: 258
Value: 9778.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Bancroft (Charles A)
Shares: 2021
Value: 76595.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Barron (Hal V)
Shares: 258
Value: 9778.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Beal (Anne M.D.)
Shares: 257
Value: 9740.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Dietz (Hal)
Shares: 257
Value: 9740.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Lee (Jeannie)
Shares: 258
Value: 9778.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-06-20
Insider: Sikka (Vishal Ph.D.)
Shares: 889
Value: 33693.00
Bought at price 37.90 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Anderson (Elizabeth McKee)
Shares: 27
Value: 1040.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Bancroft (Charles A)
Shares: 364
Value: 14028.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Barron (Hal V)
Shares: 30
Value: 1156.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Beal (Anne M.D.)
Shares: 35
Value: 1348.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Dietz (Hal)
Shares: 34
Value: 1310.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Lee (Jeannie)
Shares: 11
Value: 423.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-11
Insider: Sikka (Vishal Ph.D.)
Shares: 103
Value: 3969.00
Bought at price 38.54 per share.
Insider transaction \u2014 GSK, 2025-07-17
Insider: Barron (Hal V)
Shares: 3675
Value: 140091.00
Bought at price 38.12 per share.
Insider transaction \u2014 GSK, 2025-07-17
Insider: Ramakrishnan (Shobie)
Shares: 447
Value: 17039.00
Bought at price 38.12 per share.
Insider transaction \u2014 GSK, 2025-08-15
Insider: Barron (Hal V)
Shares: 84
Value: 3306.00
Bought at price 39.36 per share.
Insider transaction \u2014 GSK, 2025-08-15
Insider: Barron (Hal V)
Shares: 3328
Value: 130990.00
Bought at price 39.36 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Anderson (Elizabeth McKee)
Shares: 240
Value: 9777.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Bancroft (Charles A)
Shares: 1880
Value: 76591.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Barron (Hal V)
Shares: 240
Value: 9777.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Beal (Anne M.D.)
Shares: 240
Value: 9777.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Dietz (Hal)
Shares: 240
Value: 9777.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Lee (Jeannie)
Shares: 239
Value: 9736.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-09-19
Insider: Sikka (Vishal Ph.D.)
Shares: 827
Value: 33691.00
Bought at price 40.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Anderson (Elizabeth McKee)
Shares: 26
Value: 1137.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Bancroft (Charles A)
Shares: 340
Value: 14871.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Barron (Hal V)
Shares: 28
Value: 1224.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Beal (Anne M.D.)
Shares: 34
Value: 1487.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Dietz (Hal)
Shares: 32
Value: 1399.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Lee (Jeannie)
Shares: 13
Value: 568.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-10
Insider: Sikka (Vishal Ph.D.)
Shares: 99
Value: 4330.00
Bought at price 43.74 per share.
Insider transaction \u2014 GSK, 2025-10-14
Insider: Barron (Hal V)
Shares: 3187
Value: 140068.00
Bought at price 43.95 per share.
Insider transaction \u2014 GSK, 2025-10-14
Insider: Ramakrishnan (Shobie)
Shares: 387
Value: 17008.00
Bought at price 43.95 per share.
Insider transaction \u2014 GSK, 2025-11-14
Insider: Barron (Hal V)
Shares: 69
Value: 3255.00
Bought at price 47.18 per share.
Insider transaction \u2014 GSK, 2025-11-14
Insider: Barron (Hal V)
Shares: 2733
Value: 128942.00
Bought at price 47.18 per share.
Insider transaction \u2014 GSK, 2025-12-19
Insider: Anderson (Elizabeth McKee)
Shares: 201
Value: 9760.00
Bought at price 48.56 per share.
Insider transaction \u2014 GSK, 2025-12-19
Insider: Bancroft (Charles A)
Shares: 1577
Value: 76579.00
Bought at price 48.56 per share.
Insider transaction \u2014 GSK, 2025-12-19
Insider: Beal (Anne M.D.)
Shares: 201
Value: 9760.00
Bought at price 48.56 per share.
Insider transaction \u2014 GSK, 2025-12-19
Insider: Dietz (Hal)
Shares: 201
Value: 9760.00
Bought at price 48.56 per share.
Insider transaction \u2014 GSK, 2025-12-19
Insider: Lee (Jeannie)
Shares: 202
Value: 9809.00
Bought at price 48.56 per share.
Insider transaction \u2014 GSK, 2025-12-19
Insider: Sikka (Vishal Ph.D.)
Shares: 730
Value: 35448.00
Bought at price 48.56 per share.
Insider transaction \u2014 GSK, 2025-12-31
Insider: Anderson (Elizabeth McKee)
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Bancroft (Charles A)
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Barron (Hal V)
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Beal (Anne M.D.)
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Dietz (Hal)
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Dodge & Cox
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Lee (Jeannie)
Shares: 0
Insider transaction \u2014 GSK, 2025-12-31
Insider: Sikka (Vishal Ph.D.)
Shares: 0
Insider transaction \u2014 GSK, 2026-01-09
Insider: Anderson (Elizabeth McKee)
Shares: 25
Value: 1260.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-09
Insider: Bancroft (Charles A)
Shares: 316
Value: 15935.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-09
Insider: Barron (Hal V)
Shares: 28
Value: 1412.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-09
Insider: Beal (Anne M.D.)
Shares: 31
Value: 1563.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-09
Insider: Dietz (Hal)
Shares: 31
Value: 1563.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-09
Insider: Lee (Jeannie)
Shares: 13
Value: 655.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-09
Insider: Sikka (Vishal Ph.D.)
Shares: 94
Value: 4740.00
Bought at price 50.43 per share.
Insider transaction \u2014 GSK, 2026-01-14
Insider: Barron (Hal V)
Shares: 2832
Value: 142421.00
Bought at price 50.29 per share.
Insider transaction \u2014 GSK, 2026-01-14
Insider: Ramakrishnan (Shobie)
Shares: 344
Value: 17299.00
Bought at price 50.29 per share.
Insider transaction \u2014 GSK, 2026-02-05
Insider: Barron (Hal V)
Shares: 67602
Value: 4000010.00
Bought at price 59.17 per share.
Insider transaction \u2014 GSK, 2026-02-09
Insider: Conrad (D)
Shares: 13300
Value: 787094.00
Sold at price 59.18 per share.
Insider transaction \u2014 GSK, 2026-02-13
Insider: Conrad (D)
Shares: 11
Value: 911.00
Bought at price 82.82 per share.
Insider transaction \u2014 GSK, 2026-02-13
Insider: Ramakrishnan (Shobie)
Shares: 30806
Value: 1812933.00
Sold at price 58.85 per share.
Insider transaction \u2014 GSK, 2026-02-13
Insider: Ramakrishnan (Shobie)
Shares: 59379
Insider transaction \u2014 GSK, 2026-02-20
Insider: Barron (Hal V)
Shares: 64
Value: 3809.00
Bought at price 59.52 per share.
Insider transaction \u2014 GSK, 2026-02-20
Insider: Barron (Hal V)
Shares: 2008
Value: 119516.00
Bought at price 59.52 per share.
Insider transaction \u2014 GSK, 2026-02-25
Insider: Anderson (Elizabeth McKee)
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Bancroft (Charles A)
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Barron (Hal V)
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Beal (Anne M.D.)
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Dietz (Hal)
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Dodge & Cox
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Lee (Jeannie)
Shares: 0
Insider transaction \u2014 GSK, 2026-02-25
Insider: Sikka (Vishal Ph.D.)
Shares: 0
Insider transaction \u2014 GSK, 2026-03-02
Insider: Conrad (D)
Shares: 569
Value: 33366.00
Bought at price 58.64 per share.
Insider transaction \u2014 GSK, 2026-03-16
Insider: Conrad (D)
Shares: 12
Value: 652.00
Bought at price 54.41 per share.
Insider transaction \u2014 GSK, 2026-03-20
Insider: Anderson (Elizabeth McKee)
Shares: 196
Value: 13540.00
Bought at price 69.08 per share.
Insider transaction \u2014 GSK, 2026-03-20
Insider: Bancroft (Charles A)
Shares: 1536
Value: 79549.00
Bought at price 51.79 per share.
Insider transaction \u2014 GSK, 2026-03-20
Insider: Beal (Anne M.D.)
Shares: 196
Value: 10150.00
Bought at price 51.79 per share.
Insider transaction \u2014 GSK, 2026-03-20
Insider: Dietz (Hal)
Shares: 196
Value: 10150.00
Bought at price 51.79 per share.
Insider transaction \u2014 GSK, 2026-03-20
Insider: Lee (Jeannie)
Shares: 195
Value: 10099.00
Bought at price 51.79 per share.
Insider transaction \u2014 GSK, 2026-03-20
Insider: Sikka (Vishal Ph.D.)
Shares: 797
Value: 41276.00
Bought at price 51.79 per share.
Insider transaction \u2014 GSK, 2026-03-23
Insider: Martinez-Davis (Maya)
Shares: 7
Value: 363.00
Bought at price 51.99 per share.
Insider transaction \u2014 GSK, 2026-03-24
Insider: Conrad (D)
Shares: 428
Value: 22268.00
Bought at price 52.03 per share.
Insider transaction \u2014 GSK, 2026-03-30
Insider: Conrad (D)
Shares: 12
Value: 653.00
Bought at price 54.47 per share.
Insider transaction \u2014 GSK, 2026-04-07
Insider: Martinez-Davis (Maya)
Shares: 9
Value: 502.00
Bought at price 55.84 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Anderson (Elizabeth McKee)
Shares: 26
Value: 1532.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Bancroft (Charles A)
Shares: 313
Value: 18445.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Barron (Hal V)
Shares: 26
Value: 1532.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Beal (Anne M.D.)
Shares: 32
Value: 1885.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Dietz (Hal)
Shares: 30
Value: 1767.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Lee (Jeannie)
Shares: 14
Value: 825.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-09
Insider: Sikka (Vishal Ph.D.)
Shares: 96
Value: 5657.00
Bought at price 58.93 per share.
Insider transaction \u2014 GSK, 2026-04-13
Insider: Conrad (D)
Shares: 65
Value: 3792.00
Bought at price 58.35 per share.
Insider transaction \u2014 GSK, 2026-04-13
Insider: Conrad (D)
Shares: 11
Value: 641.00
Bought at price 58.34 per share.
Insider transaction \u2014 GSK, 2026-04-14
Insider: Martinez-Davis (Maya)
Shares: 152
Value: 8870.00
Bought at price 58.36 per share.
Insider transaction \u2014 GSK, 2026-04-14
Insider: Martinez-Davis (Maya)
Shares: 293
Value: 17336.00
Bought at price 59.17 per share.
Insider transaction \u2014 GSK, 2026-04-14
Insider: Ramakrishnan (Shobie)
Shares: 601
Value: 35561.00
Bought at price 59.17 per share.
Insider transaction \u2014 GSK, 2026-04-22
Insider: Martinez-Davis (Maya)
Shares: 6
Value: 334.00
Bought at price 55.70 per share.
Insider transaction \u2014 GSK, 2026-04-27
Insider: Conrad (D)
Shares: 13
Value: 709.00
Bought at price 54.59 per share.
Insider transaction \u2014 GSK, 2026-04-28
Insider: Dodge & Cox
Shares: 21373688
Insider transaction \u2014 GSK, 2026-05-15
Insider: Barron (Hal V)
Shares: 74
Value: 3675.00
Bought at price 49.67 per share.
Insider transaction \u2014 GSK, 2026-05-22
Insider: Martinez-Davis (Maya)
Shares: 10
Value: 513.00
Bought at price 51.38 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Anderson (Elizabeth McKee)
Shares: 789
Value: 39994.00
Bought at price 50.69 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Bancroft (Charles A)
Shares: 1855
Value: 94029.00
Bought at price 50.69 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Beal (Anne M.D.)
Shares: 745
Value: 37764.00
Bought at price 50.69 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Dietz (Hal)
Shares: 667
Value: 33810.00
Bought at price 50.69 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Lee (Jeannie)
Shares: 802
Value: 40653.00
Bought at price 50.69 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Martinez-Davis (Maya)
Shares: 9
Value: 456.00
Bought at price 50.74 per share.
Insider transaction \u2014 GSK, 2026-06-22
Insider: Sikka (Vishal Ph.D.)
Shares: 1266
Value: 64173.00
Bought at price 50.69 per share.
Insider transaction \u2014 GSK, 2026-06-23
Insider: Dodge & Cox
Shares: 1511635
Insider transaction \u2014 GSK, 2026-06-24
Insider: Dodge & Cox
Shares: 1056250
Insider transaction \u2014 GSK, 2026-07-07
Insider: Martinez-Davis (Maya)
Shares: 9
Value: 479.00
Bought at price 53.32 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Anderson (Elizabeth McKee)
Shares: 29
Value: 1529.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Bancroft (Charles A)
Shares: 349
Value: 18406.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Barron (Hal V)
Shares: 28
Value: 1476.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Beal (Anne M.D.)
Shares: 35
Value: 1845.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Dietz (Hal)
Shares: 35
Value: 1845.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Lee (Jeannie)
Shares: 17
Value: 896.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Martinez-Davis (Maya)
Shares: 159
Value: 8342.00
Bought at price 52.47 per share.
Insider transaction \u2014 GSK, 2026-07-10
Insider: Sikka (Vishal Ph.D.)
Shares: 109
Value: 5748.00
Bought at price 52.74 per share.
Insider transaction \u2014 GSK, 2026-07-14
Insider: Martinez-Davis (Maya)
Shares: 321
Value: 16586.00
Bought at price 51.67 per share.
Insider transaction \u2014 GSK, 2026-07-14
Insider: Ramakrishnan (Shobie)
Shares: 660
Value: 34102.00
Bought at price 51.67 per share.
Insider transaction \u2014 GSK.L, 2026-02-20
Insider: GSK Plc
Shares: 467000
Value: 13995990.00
Buy Back at price 29.97 per share.
Insider transaction \u2014 GSK.L, 2026-02-23
Insider: GSK Plc
Shares: 462000
Value: 13716318.00
Buy Back at price 29.69 per share.
Insider transaction \u2014 GSK.L, 2026-02-24
Insider: GSK Plc
Shares: 477000
Value: 14153544.00
Buy Back at price 29.67 per share.